Cited 0 times in
Clinical safety of drug-eluting stents in the Korea acute myocardial infarction registry.
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 장양수 | - |
dc.date.accessioned | 2015-05-19T16:34:42Z | - |
dc.date.available | 2015-05-19T16:34:42Z | - |
dc.date.issued | 2008 | - |
dc.identifier.issn | 1346-9843 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/106562 | - |
dc.description.abstract | BACKGROUND: Percutaneous coronary intervention (PCI) with drug-eluting stents (DES) may be useful in patients with acute myocardial infarction (AMI), but safety issues still need to be solved. This study was undertaken to investigate the incidence of major adverse cardiac events (MACE) and stent thrombosis in DES-implanted AMI patients in real-life clinical practice. METHODS AND RESULTS: On-line registry of AMI cases at the web site www.kamir.or.kr has been performed in 41 primary PCI centers in Korea and between November 2005 and September 2006, 1,541 surviving patients who had been implanted with either Cypher or Taxus stents were enrolled for analysis during a 6-month clinical follow-up. There were 2 groups: group I [834 patients, 61.9+/-11.9 years: sirolimus-eluting stent (Cypher)], group II [707 patients, 62.9+/-12.0 years: paclitaxel-eluting stent (Taxus)]. At both 1 and 6 months the incidence of MACE was not significantly different between the 2 groups. There were 17 cases of stent thrombosis, but the incidence of stent thrombosis was not significantly different between the 2 groups (group I:II=9 (1.1%):8 (1.1%), p=1.000). The stent type, length, number, lesion complexity and diabetes were not significant for the incidence of MACE or stent thrombosis after adjustment. CONCLUSION: MACE and stent thrombosis rates did not differ between 2 types of DES identified in Korea Acute Myocardial Infarction Registry (KAMIR). DES can be used in patients with AMI with a relatively low 6-month MACE rate. | - |
dc.description.statementOfResponsibility | open | - |
dc.format.extent | 392~398 | - |
dc.relation.isPartOf | CIRCULATION JOURNAL | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | AcuteDisease | - |
dc.subject.MESH | Aged | - |
dc.subject.MESH | Coronary Angiography | - |
dc.subject.MESH | Coronary Thrombosis/etiology | - |
dc.subject.MESH | Drug-Eluting Stents/adverse effects* | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Follow-Up Studies | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Korea | - |
dc.subject.MESH | Logistic Models | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Middle Aged | - |
dc.subject.MESH | Myocardial Infarction/ethnology | - |
dc.subject.MESH | Myocardial Infarction/physiopathology | - |
dc.subject.MESH | Myocardial Infarction/therapy* | - |
dc.subject.MESH | Paclitaxel | - |
dc.subject.MESH | Prospective Studies | - |
dc.subject.MESH | Registries/statistics & numerical data* | - |
dc.subject.MESH | Risk Factors | - |
dc.subject.MESH | Sirolimus | - |
dc.subject.MESH | Treatment Outcome | - |
dc.title | Clinical safety of drug-eluting stents in the Korea acute myocardial infarction registry. | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학) | - |
dc.contributor.googleauthor | Sang Rok Lee | - |
dc.contributor.googleauthor | Myung Ho Jeong | - |
dc.contributor.googleauthor | Young Keun Ahn | - |
dc.contributor.googleauthor | Shung Chull Chae | - |
dc.contributor.googleauthor | Seung Ho Hur | - |
dc.contributor.googleauthor | Young Jo Kim | - |
dc.contributor.googleauthor | In Whan Seong | - |
dc.contributor.googleauthor | Jei Keon Chae | - |
dc.contributor.googleauthor | Taek Jong Hong | - |
dc.contributor.googleauthor | Jae Young Rhew | - |
dc.contributor.googleauthor | Myeong Chan Cho | - |
dc.contributor.googleauthor | Jang Ho Bae | - |
dc.contributor.googleauthor | Seung Woon Rha | - |
dc.contributor.googleauthor | Chong Jin Kim | - |
dc.contributor.googleauthor | Yang Soo Jang | - |
dc.contributor.googleauthor | Seung Jung Park | - |
dc.identifier.doi | 18296834 | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A03448 | - |
dc.relation.journalcode | J00534 | - |
dc.identifier.eissn | 1347-4820 | - |
dc.identifier.pmid | 18296834 | - |
dc.subject.keyword | AcuteDisease | - |
dc.subject.keyword | Aged | - |
dc.subject.keyword | Coronary Angiography | - |
dc.subject.keyword | Coronary Thrombosis/etiology | - |
dc.subject.keyword | Drug-Eluting Stents/adverse effects* | - |
dc.subject.keyword | Female | - |
dc.subject.keyword | Follow-Up Studies | - |
dc.subject.keyword | Humans | - |
dc.subject.keyword | Korea | - |
dc.subject.keyword | Logistic Models | - |
dc.subject.keyword | Male | - |
dc.subject.keyword | Middle Aged | - |
dc.subject.keyword | Myocardial Infarction/ethnology | - |
dc.subject.keyword | Myocardial Infarction/physiopathology | - |
dc.subject.keyword | Myocardial Infarction/therapy* | - |
dc.subject.keyword | Paclitaxel | - |
dc.subject.keyword | Prospective Studies | - |
dc.subject.keyword | Registries/statistics & numerical data* | - |
dc.subject.keyword | Risk Factors | - |
dc.subject.keyword | Sirolimus | - |
dc.subject.keyword | Treatment Outcome | - |
dc.contributor.alternativeName | Jang, Yang Soo | - |
dc.contributor.affiliatedAuthor | Jang, Yang Soo | - |
dc.rights.accessRights | free | - |
dc.citation.volume | 72 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 392 | - |
dc.citation.endPage | 398 | - |
dc.identifier.bibliographicCitation | CIRCULATION JOURNAL, Vol.72(3) : 392-398, 2008 | - |
dc.identifier.rimsid | 44949 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.